蛋白质棕化在癌症进展,免疫力,干性以及其他方面有多种作用
Mingli Li1, Leisi Zhang1, Chun-Wei Chen1,2
1Department of Systems Biology, Beckman Research Institute, City of Hope, Duarte, CA 91010, USA.
Cells
|September 28, 2023
概括
蛋白质S-palmitoylation是一种可逆的脂质修饰,对蛋白质功能和癌症进展至关重要. 针对这一过程,为癌症治疗提供了一个有前途的治疗策略.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 蛋白质S-palmitoylation是一种可逆的翻译后修饰,涉及 palmitate 脂肪酸附着于囊类残留物.
- 这种脂质修饰影响蛋白质的疏水性,稳定性,局部化和相互作用,在细胞过程中发挥作用.
- 失调的棕细胞代谢越来越多地与瘤功能和瘤抑制有关.
研究的目的:
- 审查当前对癌症中蛋白质S-palmitoylation的理解.
- 讨论棕化对癌症进展,免疫反应和癌症干细胞特性的影响.
- 突出在癌症治疗中向棕化治疗的治疗潜力.
主要方法:
- 关于蛋白质S-palmitoylation和癌症的最近研究的文献综述.
- 对研究棕细胞代谢在癌症生物学中的作用的分析.
- 综合与向棕结合的治疗策略相关的发现.
主要成果:
- 棕化对许多瘤蛋白和瘤抑制剂的功能至关重要.
- 改变的棕化动态与癌症的发展和进展有关.
- 向棕化通路显示出作为一种抗癌治疗方法的潜力.
结论:
- 蛋白质S-palmitoylation是癌症进展和免疫逃避的关键调节者.
- 了解棕化机制为我们提供了有关癌症病原学的见解.
- 向蛋白质S-palmitoylation代表了新型癌症治疗的可行策略.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K


